Lehmann D (1987)
The time of day you inject matters less than the consistency of that timing
CrossRef Relationship between metabolic dysfunction-associated steatotic liver disease and cardiovascular mortality risk in individuals with CKM stages 02: Mediating roles of inflammation and insulin resistance Zhuoxing Li, Qianyu Yang, Li Zang, Hongwei Leng, Panpan Qin, Simeng Li, Buyuan Tian, Xumao Deng, Yun Sun, Xiang Xiao Diabetes Research and Clinical Practice .2026
Clinical trial data provides objective evidence about efficacy (24.2% weight loss at 48 weeks), safety (88.8% completion rate), side effects (peak at weeks 6-8, resolve by week 12 for most), and discontinuation outcomes (70-80% regain over 12-18 months, not immediately)
If youre searching for St
Metabolic maintenance: Blood sugar, cardiovascular protection, and other benefits similarly require ongoing treatment